1st Quarter - Report

W STRATEGIES, LLC for ABBOTT LABORATORIES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013. Education with respect to implementation issues in the Medicare Competitive Bidding program, specifically as it relates to access to brand name diabetes test strips. H.R. 4302: Protecting Access to Medicare Act of 2014, specifically as it relates to clinical lab fee schedule reforms.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4302 (113th), H.R. 2085 (113th)

Health Issues HCR

Educated staff about legislative initiatives to encourage labeling of genetically modified foods. Educated staff about FDA guidances, specifically with respect to glucose meters and certain medical foods.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Monitored legislative efforts to reform the corporate tax system.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.